Prognostic value of serial cardiac assessment and familial screening in patients with dilated cardiomyopathy

European Journal of Heart Failure

Volumn 5, Issue 1, 2003, Pages 55-62

  Grünig, Ekkehard ^a   Benz, Andreas ^a   Mereles, Derliz ^a   Unnebrink, Kristina ^a   Kücherer, Helmut ^a   Haass, Markus ^a   Kübler, Wolfgang ^a   Katus, Hugo A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Dilated cardiomyopathy; Familial cardiomyopathy; Genetics; Prognosis; Serial assessment; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FAMILY; FEMALE; HEART DILATATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCREENING; SURVIVAL RATE;

ADULT; AGED; AMBULATORY CARE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, DILATED; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037275534     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00179-4     Document Type: Article

References (20)

1. Stevenson LW, Steimle AE, Fonarow G, et al. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol 1995;25:163-70.
2. Florea VG, Henein MY, Anker SD, et al. Relation of changes over time in ventricular size and function to those in exercise capacity in patients with chronic heart failure. Am Heart J 2000;21:913-7.
3. Gullestad L, Myers J, Ross H, et al. Serial exercise testing and prognosis in selected patients considered for cardiac transplantation. Am Heart J 1998;135:221-9.
4. Brandenburg RO, Chazov E, Cherian G, et al. Report of the WHO/IFSC Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1981;64:437-8.
5. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-2.
6. Grünig E, Tasman JA, Kücherer H, et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998;31:186-94.
7. Criteria Committee of New York Heart Association. 6th ed. Nomenclature and criteria for diagnosis of the heart and great vessels. Boston: Little, Brown, 1964. p. 1-23.
8. Miyatake K, Izumi S, Okamoto M, et al. Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional doppler flow imaging technique. J Am Coll Cardiol 1986;7:82-8.
9. Greene HL, Richardson DW, Barker AH, et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the cardiac arrhythmia pilot study). Am J Cardiol 1989;21:1-6.
10. Kaplan EL, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
11. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
12. Modena MG, Muia N, Sgura FA, et al. Left atrial size is a major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long term follow-up study. Clin Cardiol 1997;20:553-60.
13. Williams JF, Bristow MR, Fowler MB, et al. Guidelines for the evaluation and management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 1995;26:1376-98.
14. Blondheim DS, Jacobs LE, Kotler MN, et al. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991;122:763-71.
15. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-86.
16. Zugck C, Krueger C, Durr S, et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 2000;21:540-9.
17. Cowburn PJ, Cleland JGF, Coats AJS, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696-710.
18. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326:77-82.
19. Csanády M, Högye M, Kallai A, et al. Familial dilated cardiomyopathy: a worse prognosis compared with sporadic forms. Br Heart J 1995;74:171-3.
20. Honda Y, Yokota Y, Yokoyama M. Familial aggregation of dilated cardiomyopathy: evaluation of clinical characteristics and prognosis. Jpn Circ J 1995;59:589-98.